Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine.
about
TRPM2 links oxidative stress to NLRP3 inflammasome activationRecent Developments of Liposomes as Nanocarriers for Theranostic Applications.Micromanaging cardiac regeneration: Targeted delivery of microRNAs for cardiac repair and regenerationBiosafe nanoscale pharmaceutical adjuvant materialsNanotheranostics - application and further development of nanomedicine strategies for advanced theranosticsCell or cell membrane-based drug delivery systemsPharmacokinetics, pharmacodynamics and toxicology of theranostic nanoparticlesLiposomes as nanomedical devicesAdvances in Integrative Nanomedicine for Improving Infectious Disease Treatment in Public HealthNanotechnologies for noninvasive measurement of drug releasePlasmonic Vesicles of Amphiphilic Nanocrystals: Optically Active Multifunctional Platform for Cancer Diagnosis and Therapy.Human Lipocalin-Type Prostaglandin D Synthase-Based Drug Delivery System for Poorly Water-Soluble Anti-Cancer Drug SN-38Metal-organic frameworks as a tunable platform for designing functional molecular materialsEnhanced cellular uptake of size-separated lipophilic silicon nanoparticlesStability of echogenic liposomes as a blood pool ultrasound contrast agent in a physiologic flow phantom.Ultrasound-mediated gene and drug delivery using a microbubble-liposome particle systemRecent trends in multifunctional liposomal nanocarriers for enhanced tumor targetingDesign and Synthesis of a γ(1)β(8)-Cyclodextrin Oligomer: A New Platform with Potential Application as a Dendrimeric Multicarrier.In situ formation of magnetopolymersomes via electroporation for MRI.A ring-flippable sugar as a stimuli-responsive component of liposomes.Magnetoliposomes loaded with poly-unsaturated fatty acids as novel theranostic anti-inflammatory formulationsFunctionalization of a Triazine Dendrimer Presenting Four Maleimides on the Periphery and a DOTA Group at the Core.Amphiphilic Ditopic Bis-Aqua Gd-AAZTA-like Complexes Enhance Relaxivity of Lipidic MRI Nanoprobes.Phase I dose-escalation study of 5-day intermittent oral lapatinib therapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer.Nanodrug delivery systems: a promising technology for detection, diagnosis, and treatment of cancer.Transferrin coated nanoparticles: study of the bionano interface in human plasma.Cytophilic/cytophobic design of nanomaterials at biointerfaces.Cationic liposomes loaded with a synthetic long peptide and poly(I:C): a defined adjuvanted vaccine for induction of antigen-specific T cell cytotoxicity.Tumor targeting, trifunctional dendritic wedge.A polymer encapsulation approach to prepare zwitterion-like, biocompatible quantum dots with wide pH and ionic stability.Rapid, one-step fabrication and loading of nanoscale 1,2-distearoyl-sn-glycero-3-phosphocholine liposomes in a simple, double flow-focusing microfluidic device.Cellulose conjugated FITC-labelled mesoporous silica nanoparticles: intracellular accumulation and stimuli responsive doxorubicin release.Theranostic liposomes loaded with quantum dots and apomorphine for brain targeting and bioimaging.Polydopamine-coated liposomes as pH-sensitive anticancer drug carriers.Near-Infrared-Triggered Azobenzene-Liposome/Upconversion Nanoparticle Hybrid Vesicles for Remotely Controlled Drug Delivery to Overcome Cancer Multidrug Resistance.Shaping bio-inspired nanotechnologies to target thrombosis for dual optical-magnetic resonance imaging.Voyage of theranostic liposomes for imaging and therapy.In vitro selection of random peptides against artificial lipid bilayers: a potential tool to immobilize molecules on membranes.Biomimetic surface engineering of lanthanide-doped upconversion nanoparticles as versatile bioprobes.Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives.
P2860
Q24600251-B081B308-D79E-4062-A066-99AE1153E1ECQ26744835-78537ABE-AC82-4EAD-AFF8-18C0DEF7FFF6Q26765166-59F95E1E-764F-4849-9B90-9385E278F880Q26829798-F05D9A54-3685-44C1-9603-157950F53054Q26860760-ABBE719C-1271-4994-BC76-D47C9BF4DF48Q28080710-555D0176-B1A1-40C6-A170-F4BAC060B945Q28084443-2EA7CCEA-97F7-40EA-A546-D280BE14BBA4Q28088315-7E2B743C-86B5-4362-87EE-D420F5F186DFQ28384520-B51FCD4B-BE97-4AB2-A6C2-76EE25CBFD2EQ28387499-4A5F2F1B-3023-4438-BD92-C67739F705EAQ28468538-87AE130B-6D1C-4C21-9108-4B8A89480E27Q28550622-6ABD3F94-4A00-44FF-BE1A-7AAA00DA623DQ28662327-601813C6-4C9A-45F9-8964-5E2627147E2FQ29248383-4A425115-3EB0-4E25-8AB7-DCA60C361AF9Q30380934-9DEA3C72-8F21-4766-9060-3DD04521E89BQ30430371-375FC899-11BE-4563-BE7F-253A901F7B74Q30456053-C59E1257-AEB4-4CFF-BE80-E0D072E229EAQ30656491-758F4B20-E9B4-483B-97F2-6BFB44620888Q30665894-FE48B403-8BA4-4845-87EE-4DB9247B13D9Q30883707-2D622CB5-7782-4AC7-B3CA-FDA0D5AA8038Q30909702-9EC89379-AB52-4604-970E-C3ADF919CF06Q31058567-B8D9B511-B564-4127-B347-BDBC85AAD2BBQ31109393-B2D89977-6FB2-475C-80F4-DCE909417527Q33597447-8CA7E2A8-1A92-4651-82D0-07B38E5045CDQ33681168-BEFADFC0-129C-4ED3-BD43-3CEF0A30C854Q34351046-CE585C8E-E799-4956-BA35-6620E15C555FQ34589395-47A5F4F8-7AA9-43E0-B1F7-BD8BE01988A1Q34871801-DBE4C770-997D-4CAE-844D-825FE84AD86EQ35013469-8E1BB1FF-3C02-4ED7-A894-78AE0E238AEBQ35137221-C411479F-158C-4BCC-8129-6216D530AD32Q35693288-C5F6C7AB-5552-4A08-A375-B7A559104883Q35921552-99196021-D228-43A6-B313-7C101A37A31CQ35972521-422CD1CC-1BBD-4E71-B520-3EBA5298653CQ36016481-C9C83EDE-A5D8-4C2F-AFE3-1D6BF2D946FCQ36118030-678E93A5-E865-4D47-B3CD-BC966C7E7685Q36204756-3C02B2F8-37BD-48B4-837F-9E17579B58AFQ36264100-1F6096DB-C94B-46BD-9C2D-BD5A3D86E002Q36300321-D568D162-125C-4D2A-8CA9-52A62BA9843CQ36452643-6B76D1A4-6D49-4C1E-A0F5-C6236C3E234DQ36777292-F872F0ED-D8F1-4AB9-B869-42664040AABD
P2860
Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Liposomes: from a clinically e ...... for theranostic nanomedicine.
@en
Liposomes: from a clinically e ...... for theranostic nanomedicine.
@nl
type
label
Liposomes: from a clinically e ...... for theranostic nanomedicine.
@en
Liposomes: from a clinically e ...... for theranostic nanomedicine.
@nl
prefLabel
Liposomes: from a clinically e ...... for theranostic nanomedicine.
@en
Liposomes: from a clinically e ...... for theranostic nanomedicine.
@nl
P356
P1476
Liposomes: from a clinically e ...... m for theranostic nanomedicine
@en
P2093
Wafa' T Al-Jamal
P304
P356
10.1021/AR200105P
P407
P577
2011-08-03T00:00:00Z